Ironwood Pharma (IRWD) Tops Q3 EPS by 29c, Revenues Beat; Boosts FY19 Revenue Guidance Above Consensus

October 31, 2019 7:30 AM

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.40, $0.29 better than the analyst estimate of $0.11. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found